JGUA
AMGN icon

John G. Ullman & Associates’s Amgen AMGN Stock Holding History

John G. Ullman & Associates’s Portfolio AMGN Stock Details AMGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$748K Sell
2,125
-6,675
-76% -$2.38M 0.1% 115
2025
Q4 		$2.88M Sell
8,800
-200
-2% -$63.4K 0.38% 74
2025
Q3 		$2.54M Sell
9,000
-71
-0.8% -$20.6K 0.34% 74
2025
Q2 		$2.53M Sell
9,071
-219
-2% -$62K 0.38% 73
2025
Q1 		$2.89M Sell
9,290
-80
-0.9% -$23.6K 0.45% 74
2024
Q4 		$2.44M Buy
9,370
+20
+0.2% +$5.93K 0.36% 78
2024
Q3 		$3.01M Sell
9,350
-1,114
-11% -$364K 0.43% 72
2024
Q2 		$3.27M Hold
10,464
– – 0.5% 63
2024
Q1 		$2.98M Sell
10,464
-350
-3% -$102K 0.46% 67
2023
Q4 		$3.11M Sell
10,814
-130
-1% -$35.4K 0.49% 63
2023
Q3 		$2.94M Sell
10,944
-50
-0.5% -$12.5K 0.48% 61
2023
Q2 		$2.44M Sell
10,994
-94
-0.8% -$21.8K 0.38% 77
2023
Q1 		$2.68M Sell
11,088
-127
-1% -$31.2K 0.42% 65
2022
Q4 		$2.95M Buy
11,215
+75
+0.7% +$20.1K 0.47% 56
2022
Q3 		$2.51M Sell
11,140
-50
-0.4% -$12.1K 0.44% 60
2022
Q2 		$2.72M Hold
11,190
– – 0.44% 59
2022
Q1 		$2.71M Sell
11,190
-110
-1% -$25.3K 0.37% 62
2021
Q4 		$2.54M Buy
11,300
+4,610
+69% +$973K 0.35% 66
2021
Q3 		$1.42M Hold
6,690
– – 0.19% 81
2021
Q2 		$1.63M Hold
6,690
– – 0.21% 74
2021
Q1 		$1.67M Sell
6,690
-1,500
-18% -$358K 0.22% 69
2020
Q4 		$1.88M Hold
8,190
– – 0.29% 67
2020
Q3 		$2.08M Sell
8,190
-5
-0.1% -$1.24K 0.43% 54
2020
Q2 		$1.93M Buy
8,195
+5
+0.1% +$1.14K 0.47% 47
2020
Q1 		$1.66M Hold
8,190
– – 0.44% 52
2019
Q4 		$1.97M Sell
8,190
-3,432
-30% -$757K 0.34% 67
2019
Q3 		$2.25M Hold
11,622
– – 0.41% 58
2019
Q2 		$2.14M Buy
11,622
+172
+2% +$30.8K 0.38% 60
2019
Q1 		$2.17M Sell
11,450
-100
-0.9% -$19.1K 0.39% 60
2018
Q4 		$2.25M Sell
11,550
-93
-0.8% -$18.1K 0.45% 56
2018
Q3 		$2.41M Buy
11,643
+100
+0.9% +$19.7K 0.44% 58
2018
Q2 		$2.13M Sell
11,543
-15
-0.1% -$2.65K 0.4% 60
2018
Q1 		$1.97M Sell
11,558
-1,050
-8% -$193K 0.38% 59
2017
Q4 		$2.19M Sell
12,608
-150
-1% -$26.5K 0.44% 58
2017
Q3 		$2.38M Sell
12,758
-3,713
-23% -$658K 0.46% 61
2017
Q2 		$2.84M Hold
16,471
– – 0.56% 58
2017
Q1 		$2.7M Sell
16,471
-3,250
-16% -$540K 0.56% 58
2016
Q4 		$2.88M Sell
19,721
-892
-4% -$134K 0.6% 54
2016
Q3 		$3.44M Sell
20,613
-200
-1% -$33.8K 0.71% 52
2016
Q2 		$3.17M Sell
20,813
-167
-0.8% -$26K 0.65% 51
2016
Q1 		$3.15M Sell
20,980
-794
-4% -$118K 0.74% 45
2015
Q4 		$3.54M Sell
21,774
-1,056
-5% -$166K 0.78% 40
2015
Q3 		$3.16M Sell
22,830
-9,213
-29% -$1.45M 0.75% 40
2015
Q2 		$4.92M Sell
32,043
-750
-2% -$120K 0.93% 34
2015
Q1 		$5.24M Sell
32,793
-1,150
-3% -$181K 1% 31
2014
Q4 		$5.41M Sell
33,943
-13,305
-28% -$2.07M 1.02% 28
2014
Q3 		$6.64M Sell
47,248
-16,599
-26% -$2.17M 1.28% 22
2014
Q2 		$7.56M Sell
63,847
-1,675
-3% -$194K 1.38% 22
2014
Q1 		$8.08M Sell
65,522
-3,368
-5% -$408K 1.5% 20
2013
Q4 		$7.86M Sell
68,890
-975
-1% -$111K 1.5% 20
2013
Q3 		$7.82M Sell
69,865
-17,798
-20% -$1.93M 1.59% 18
2013
Q2 		$8.65M Buy
+87,663
New +$9.1M 1.81% 16

Other funds holding AMGN

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

John G. Ullman & Associates's AMGN Position: Q1 2026 in Review

John G. Ullman & Associates reduced its Amgen (AMGN) stake by 76% in Q1 2026, selling an estimated $2.38M and leaving 2,125 shares worth $748K. The position accounts for 0.1% of the portfolio, ranked #115.

John G. Ullman & Associates first reported a position in AMGN in Q2 2013 and has held it in 52 quarters since. The position peaked at $8.65M in Q2 2013. 3,130 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.

  • John G. Ullman & Associates held 2,125 shares of Amgen worth $748K as of Q1 2026.
  • John G. Ullman & Associates sold 6,675 Amgen shares in Q1 2026, an estimated $2.38M.
  • Amgen made up 0.1% of John G. Ullman & Associates's portfolio in Q1 2026, its #115 holding.
  • John G. Ullman & Associates first reported a position in Amgen in Q2 2013 and has held it in 52 quarters since.
  • John G. Ullman & Associates's Amgen position peaked at $8.65M in Q2 2013.
  • 3,130 funds tracked by Wall St. Rank held Amgen as of Q1 2026.

Based on John G. Ullman & Associates's 13F filing for Q1 2026, filed 6 May 2026.